PHARMADRO P 100

Description

Chemical name: (2α,5α,17β)-2-Methyl-3-oxoandrostan-17-yl propanoate Formula: C23H36O3 Anabolic activity index: 62% Androgenic activity index: 25% PHARMADRO P100 – PHARMACOM LABS 1 VIAL X 10 ML X 100 MG/ML PHARMADRO P100 (Drostanolone propionate) stands out as a highly effective option for achieving lean and dense muscles, offering an excellent price-quality ratio. With a relatively short half-life of approximately 1-1.5 days, it is particularly well-suited for shorter and cutting cycles, making it a popular choice among athletes. Benefits: Lean Muscle Development: Ideal for acquiring lean and dense muscle mass. Fast-Acting: Short half-life enables quick results, perfect for cutting cycles. History and Development: First described in 1959, entered the market in 1970 under the trade name Masteron. Anti-Estrogenic Traits: Displays strong anabolic properties with anti-estrogenic characteristics. FDA Approval: Approved for treating inoperable breast cancer in climacteric women. Muscle Definition: Does not cause water retention, providing improved muscle density, relief, and definition. Lipolytic Effect: Facilitates fat reduction, contributing to enhanced muscle condition. Bulking Use: While weak as a bulking agent, it offers moderate gains in mass. Estrogenic Safety: Does not aromatize, exhibits anti-estrogenic traits, and binds to aromatase. Side Effects: Limited Bulking Effects: Relatively weak for bulking compared to other steroids. Condition-Dependent Effects: Most effective when the user is extremely lean. Bulking Consideration: May not provide substantial mass gains in a bulking-focused regimen. Dosage Instructions: Cycle Duration: Suitable for shorter cycles due to its fast-acting nature. Lean Muscle Focus: Best results achieved when aiming for lean muscle development. Cutting Cycle Recommendation: Particularly beneficial for cutting cycles. Safe Alternative: Compared to stanozolol, seen as a reasonable and safer option for cutting cycles.